Clinical and Molecular Hepatology
ISSN:2287-2728

Clinical and Molecular Hepatology

CLIN MOL HEPATOL
学科领域:医学
是否预警:不在预警名单内
是否OA:
录用周期:10 Weeks
新锐分区:医学1区
年发文量:58
影响因子:16.9
JCR分区:Q1

基本信息

临床和分子肝病学(Clin Mol Hepatology)是一种国际性、同行评审、开放获取期刊,每季度以英语出版。《临床与分子肝病》旨在分享肝胆疾病的先进和最新知识、趋势和理解,为临床医生、转化研究人员和基础科学家提供一个广泛开放的学术论坛,并通过多学科方法改善公共卫生,特别是在B病毒感染和肝细胞癌高发的资源有限的亚太地区。此外,《临床分子肝病学》还重点研究东亚、北亚、东南亚、中亚、南亚、西南亚、太平洋、非洲、中欧、东欧、中美洲和南美洲的肝胆疾病的流行病学研究。
2287-2728SCIE/Scopus收录/DOAJ开放期刊
16.9
20.6
2026年3月发布
点击查看历史分区趋势    >
大类学科小类学科Top期刊综述期刊
医学1区
GASTROENTEROLOGY & HEPATOLOGY 胃肠肝病学
1区
N/A
WOS期刊SCI分区  2024-2025最新升级版
按JIF指标学科分区收集子录JIF分区JIF排名百分位
学科:GASTROENTEROLOGY & HEPATOLOGY
SCIE
Q1
6/148
按JCR指标学科分区收集子录JCR分区JCR排名百分位
学科:GASTROENTEROLOGY & HEPATOLOGY
SCIE
Q1
8/148
暂无h-index数据
58
5%-10 WeeksKRW42000Medicine-Hepatology
6.5%
时间预警情况
2026年03月发布的新锐学术版不在预警名单中
2025年03月发布的2025版不在预警名单中
2024年02月发布的2024版不在预警名单中
2023年01月发布的2023版不在预警名单中
2021年12月发布的2021版不在预警名单中
2020年12月发布的2020版不在预警名单中
74.14%100%-
CiteScore:19.70
SJR:3.635
SNIP:3.019
学科类别分区排名百分位
大类:Biochemistry, Genetics and Molecular Biology
小类:Molecular Biology
Q1
21 / 410
大类:Biochemistry, Genetics and Molecular Biology
小类:Hepatology
Q1
6 / 87

期刊高被引文献

Recent research trends and updates on nonalcoholic fatty liver disease
来源期刊:Clinical and Molecular HepatologyDOI:10.3350/cmh.2018.0037
Radiomics and radiogenomics of primary liver cancers
来源期刊:Clinical and Molecular HepatologyDOI:10.3350/cmh.2018.1007
Unmet need in chronic hepatitis B management
来源期刊:Clinical and Molecular HepatologyDOI:10.3350/cmh.2018.0106
Application of transient elastography in nonalcoholic fatty liver disease
来源期刊:Clinical and Molecular HepatologyDOI:10.3350/cmh.2019.0001n
Pathologic differential diagnosis of metastatic carcinoma in the liver
来源期刊:Clinical and Molecular HepatologyDOI:10.3350/cmh.2018.0067
Hepatocellular carcinoma surveillance in the 21st century: Saving lives or causing harm?
来源期刊:Clinical and Molecular HepatologyDOI:10.3350/cmh.2019.1001
Association between hepatic steatosis and the development of hepatocellular carcinoma in patients with chronic hepatitis B
来源期刊:Clinical and Molecular HepatologyDOI:10.3350/cmh.2018.0040
Detect or not to detect very early stage hepatocellular carcinoma? The western perspective
来源期刊:Clinical and Molecular HepatologyDOI:10.3350/cmh.2019.0010
Development and surveillance of hepatocellular carcinoma in patients with sustained virologic response after antiviral therapy for chronic hepatitis C
来源期刊:Clinical and Molecular HepatologyDOI:10.3350/cmh.2018.0108
Ultraselective conventional transarterial chemoembolization: When and how?
来源期刊:Clinical and Molecular HepatologyDOI:10.3350/cmh.2019.0016
Discussion on critical points for a tailored therapy to cure hepatitis C virus infection
来源期刊:Clinical and Molecular HepatologyDOI:10.3350/cmh.2018.0061
Underlying liver disease and advanced stage liver cancer are associated with elevated neutrophil-lymphocyte ratio
来源期刊:Clinical and Molecular HepatologyDOI:10.3350/cmh.2019.0004
Direct-acting antivirals-based therapy decreases hepatic fibrosis serum biomarker microfibrillar-associated protein 4 in hepatitis C patients
来源期刊:Clinical and Molecular HepatologyDOI:10.3350/cmh.2018.0029
A survey on transarterial chemoembolization refractoriness and a real-world treatment pattern for hepatocellular carcinoma in Korea
来源期刊:Clinical and Molecular HepatologyDOI:10.3350/cmh.2018.0065
Sensitivity of ultrasound in detecting hepatocellular carcinoma in obese patients compared to explant pathology as the gold standard
来源期刊:Clinical and Molecular HepatologyDOI:10.3350/cmh.2019.0039
Extrahepatic manifestations of hepatitis E virus: An overview
来源期刊:Clinical and Molecular HepatologyDOI:10.3350/cmh.2019.0082
Gadoxetic acid-enhanced magnetic resonance imaging: Hepatocellular carcinoma and mimickers
来源期刊:Clinical and Molecular HepatologyDOI:10.3350/cmh.2018.0107
Upcoming direct acting antivirals for hepatitis C patients with a prior treatment failure
来源期刊:Clinical and Molecular HepatologyDOI:10.3350/cmh.2019.0022
Sarcopenia: Ammonia metabolism and hepatic encephalopathy
来源期刊:Clinical and Molecular HepatologyDOI:10.3350/cmh.2019.0015
Serum Wisteria floribunda agglutinin-positive human Mac-2 binding protein level predicts recurrence of hepatitis B virus-related hepatocellular carcinoma after curative resection
来源期刊:Clinical and Molecular HepatologyDOI:10.3350/cmh.2018.0073
Endoscopic treatment or balloon-occluded retrograde transvenous obliteration is safe for patients with esophageal/gastric varices in Child-Pugh class C end-stage liver cirrhosis
来源期刊:Clinical and Molecular HepatologyDOI:10.3350/cmh.2018.0039
Drug induced liver injury: East versus West – a systematic review and meta-analysis
来源期刊:Clinical and Molecular HepatologyDOI:10.3350/cmh.2019.1003
Bi-monthly hepatic arterial infusion chemotherapy as a novel strategy for advanced hepatocellular carcinoma in decompensated cirrhotic patients
来源期刊:Clinical and Molecular HepatologyDOI:10.3350/cmh.2019.0037
KASL clinical practice guidelines for management of chronic hepatitis B
来源期刊:Clinical and Molecular HepatologyDOI:10.3350/cmh.2019.1002
An integrated analysis of elbasvir/grazoprevir in Korean patients with hepatitis C virus genotype 1b infection
来源期刊:Clinical and Molecular HepatologyDOI:10.3350/cmh.2019.0006
Direct-acting antivirals response in hepatocellular carcinoma: Does the presence of hepatocellular carcinoma matter?
来源期刊:Clinical and Molecular HepatologyDOI:10.3350/cmh.2018.1014
Effects of different exercise modalities on novel hepatic steatosis indices in overweight women with type 2 diabetes
来源期刊:Clinical and Molecular HepatologyDOI:10.3350/cmh.2018.0086
Effects of zolpidem on sleep parameters in patients with cirrhosis and sleep disturbances: A randomized, placebo-controlled trial
来源期刊:Clinical and Molecular HepatologyDOI:10.3350/cmh.2018.0084
The management of polycystic liver disease by tolvaptan
来源期刊:Clinical and Molecular HepatologyDOI:10.3350/cmh.2019.0026
Limited expression of TLR9 on T cells and its functional consequences in patients with nonalcoholic fatty liver disease
来源期刊:Clinical and Molecular HepatologyDOI:10.3350/cmh.2019.0074
Vimentin as a potential therapeutic target in sorafenib resistant HepG2, a HCC model cell line
来源期刊:Clinical and Molecular HepatologyDOI:10.3350/cmh.2019.0031
Immunologic strategies and outcomes in ABO-incompatible living donor liver transplantation
来源期刊:Clinical and Molecular HepatologyDOI:10.3350/cmh.2019.0023
Advances in ultrasound diagnosis in chronic liver diseases
来源期刊:Clinical and Molecular HepatologyDOI:10.3350/cmh.2018.1013
Biomarker microfibril-associated glycoprotein 4 for non-invasive diagnosis and therapeutic evaluation of hepatic fibrosis in patients with hepatitis C
来源期刊:Clinical and Molecular HepatologyDOI:10.3350/cmh.2018.1011
The fibrogenic process and the unleashing of acute-on-chronic liver failure
来源期刊:Clinical and Molecular HepatologyDOI:10.3350/cmh.2019.0011
Risk assessment of hepatocellular carcinoma development for indeterminate hepatic nodules in patients with chronic hepatitis B
来源期刊:Clinical and Molecular HepatologyDOI:10.3350/cmh.2018.0103
Evaluation of bioenergetic and mitochondrial function in liver transplantation
来源期刊:Clinical and Molecular HepatologyDOI:10.3350/cmh.2018.0087
Portal pressure gradient and serum albumin: A simple combined parameter associated with the appearance of ascites in decompensated cirrhosis treated with transjugular intrahepatic portosystemic shunt
来源期刊:Clinical and Molecular HepatologyDOI:10.3350/cmh.2018.0083
Biochemical profile in an infant with neonatal hemochromatosis shows evidence of impairment of mitochondrial long-chain fatty acid oxidation
来源期刊:Clinical and Molecular HepatologyDOI:10.3350/cmh.2018.0005
Are there differences in risk factors, microbial aspects, and prognosis of cellulitis between compensated and decompensated hepatitis C virus-related cirrhosis?
来源期刊:Clinical and Molecular HepatologyDOI:10.3350/cmh.2018.0097
Role of endoscopic treatment or balloon-occluded retrograde transvenous obliteration in patients with Child-Pugh class C end-stage liver cirrhosis and esophageal/gastric varices
来源期刊:Clinical and Molecular HepatologyDOI:10.3350/cmh.2018.1010
Can hepatic steatosis really promote hepatitis B viral hepatocarcinogenesis? The jury is out on.
来源期刊:Clinical and Molecular HepatologyDOI:10.3350/cmh.2018.0101
Clinical characteristics of portal hypertension complicated by gastroesophageal varices in patients with my- eloproliferative neoplasms
来源期刊:Clinical and Molecular HepatologyDOI:10.3350/cmh.2019.0078
Serum leptin in non-alcoholic fatty liver disease: Ambiguous clinical implications concerning cardiovascular disease
来源期刊:Clinical and Molecular HepatologyDOI:10.3350/cmh.2019.0034
Transjugular intrahepatic portosystemic shunt assisted with trans-splenic access
来源期刊:Clinical and Molecular HepatologyDOI:10.3350/cmh.2019.0030
Influence of some methylated hepatocarcinogenesis-related genes on the response to antiviral therapy and development of fibrosis in chronic hepatitis C patients
来源期刊:Clinical and Molecular HepatologyDOI:10.3350/cmh.2019.0051
Hepatitis B screening rates and reactivation in solid organ malignancy patients undergoing chemotherapy in Southern Thailand
来源期刊:Clinical and Molecular HepatologyDOI:10.3350/cmh.2018.0111
Fibrolamellar hepatocellular carcinoma-related hyperammonemic encephalopathy: Up to now and next steps
来源期刊:Clinical and Molecular HepatologyDOI:10.3350/cmh.2019.0084
Efficacy of L-carnitine on ribavirin-induced hemolytic anemia in patients with hepatitis C virus infection
来源期刊:Clinical and Molecular HepatologyDOI:10.3350/cmh.2018.0070
Multimodal sequential treatment for occluded TIPS: Case report and review of literature
来源期刊:Clinical and Molecular HepatologyDOI:10.3350/cmh.2019.0056

相关文章

2026年3月发布(新锐分区)
大类学科小类学科Top期刊综述期刊
医学1区
GASTROENTEROLOGY & HEPATOLOGY 胃肠肝病学
1区
N/A
2025年3月升级版
大类学科小类学科Top期刊综述期刊
医学1区
GASTROENTEROLOGY & HEPATOLOGY 胃肠肝病学
1区
2023年12月旧的升级版
大类学科小类学科Top期刊综述期刊
医学1区
GASTROENTEROLOGY & HEPATOLOGY 胃肠肝病学
2区